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Replacement tissues for tissue engineering can be produced by seeding human cells onto scaffolds. 
In order to guarantee adequate bio-compatibility, porosity and mechanical resistance for promoting 
cellular growth, proliferation and differentiation within scaffold structures, it is necessary to investigate 
and improve materials and processing routes. β-tricalcium phosphate can be considered a very suitable 
bio-ceramic material for bone therapy because of its biocompatibility, osteo-conductivity and neo-
vascularization potential. Alumina is commonly used as a sintering additive. In this study, β-TCP and 
β-TCP/Al2O3 scaffolds were obtained by gel-casting method. The scaffolds showed high porosity (86-
88%) and pore sizes ranging from 200 to 500 μm. Even though alumina did not promote improvement 
in β-TCP/Al2O3 scaffolds in terms of mechanical performance, they showed great cytocompatibility 
as there was no cytotoxic and genotoxic effect. Therefore, β-TCP and β-TCP/Al2O3 scaffolds are good 
candidates for application in tissue engineering.
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1. Introduction
Tissue engineering is a scientific field that integrates 
biological components, such as cells and growth factors, with 
engineering principles and synthetic materials. Therefore, 
as an interdisciplinary field, tissue engineering concerns the 
development of biological substitutes capable of replacing or 
repairing diseased or damaged tissue and organs in humans1-4. 
Since the 80’s, and especially in the last decade, tissue 
engineering and regenerative medicine have been proving 
its importance and potential to revolutionize important areas 
of medicine1-4, such as cardiovascular5-6, skin regeneration7 
and bone treatments8-11. 
Replacement tissues can be produced by first seeding 
human cells onto scaffolds1-4. Scaffolds are temporary 
support structures that provide adequate conditions for cell 
proliferation, migration, and differentiation in 3D, allowing 
formation of specific tissues with appropriate functions. Some 
common properties of an ideal scaffold for tissue engineering 
are biocompatibility, porosity with interconnected pores 
and adequate mechanical strength, depending mainly on the 
tissue to be repaired 1-2,4,10-11. 
An ideal scaffold porosity is required to maximize the 
space for cellular adhesion, growth, revascularization, adequate 
nutrition and other factors that can influence cellular and 
tissue growth1-4,9-10. Different methods have been studied and 
improved in the past years to obtain scaffolds with desired 
properties1,10, such as porogen particles12, emulsion13-15, 
replication8,16, gel-casting of foams12,14,16-18 and additive 
manufacture19. 
Gel-casting method consists in adding a foaming agent 
to a ceramic suspension composed of ceramic powder, 
organic monomers and dispersants, thus providing a 
mechanical action. After gelation of the foam due to in situ 
polymerization of water-soluble monomers (previously 
added to the ceramic suspension) and its sintering, some 
of the scaffold properties produced were: ideal porosity 
(40–90%) and porous morphology with spherical-shaped 
pores measuring between 50 and 800 mm, and thick walls 
with homogeneous micro-structure, thus improving the 
mechanical properties of these materials, which can help 
cellular growth. Furthermore, this method is cheaper than 
others and does not require atmospheric control20-23.
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Bone scaffolds can have an optimal performance so long 
as they can be bio-degradable, bio-resorbable and capable of 
providing mechanical support for repair and regeneration of 
diseased or damaged bone while the growing tissue replaces 
the scaffold1-4,9-10. 
There are many ceramic materials that have been used 
for bone tissue engineering, such as calcium phosphates, 
especially hydroxyapatite (HA)1,12,16,18 and β-tricalcium 
phosphate (β-TCP)1,8,16, bioactive glass24,25 and titania26. 
Tricalcium phosphate (TCP) is a bio-resorbable, bio-active 
and osteo-conductive bio-ceramic material. Also, the β-TCP 
phase, one of its four polymorphic phases, stands out due to 
its solubility, degradation rate and higher angiogenic activity 
compared to other calcium phosphates, which is highly related 
to the process of neo-vascularization of new tissues27-32.
Unfortunately, β-TCP undergoes a β→α polymorphic 
transformation while being processed, which takes place 
at temperatures as low as 1150 ºC28,32. As a straightforward 
consequence, a poor mechanical performance (e.g. compressive 
strength) attributed to porous structures is more pronounced, 
limiting its application. Also, the porosity increases the 
complexity for manufacturing reproducible scaffolds.
One way to improve such mechanical properties would 
be to use sintering additives, which could improve the 
thermal stability of β-TCP or form a liquid phase during 
sintering, either process favoring material densification33-36. 
Among the various additives (e.g. alumina, titania, calcium 
pyrophosphate, zirconium, magnesium and others), alumina 
stands out due to the combination of its excellent corrosion 
resistance, good bio-compatibility, high wear resistance, high 
compressive strength and high hardness37. For this reason, 
alumina is commonly used to improve β-TCP densification 
during sintering35.
In the literature, there are few reports about bio-ceramic 
materials produced by gel-casting method17,38-39. Thus, this 
manuscript makes a scientific contribution to the processing of 
bio-ceramic materials with high porosity, adequate sphericity 
and high interconnectivity all desirable characteristics for 
a good scaffold.
Based on this context, the current work reports the 
preparation of β-TCP and β-TCP/Al2O3 scaffolds by using gel-
casting of foams with appropriate porosity, interconnectivity 
and bio-active behavior for application in tissue engineering.
2. Materials and Methods
2.1. Fabrication of β-TCP and β-TCP/Al2O3 
scaffolds
β-TCP powder was synthesized by means of solid-state 
reaction at 1050 ºC from an appropriate mixture of calcium 
carbonate (CaCO3 – Synth) and calcium phosphate (CaHPO4 – 
Synth), as already published elsewhere40. The resulting powder 
was ballmilled for 48 hours (alumina grinding media with 10 
mm spheres at ball/powder ratio of 10:1) and presented a mean 
size of 3.4 µm and particle size distribution of 0.3-26 µm.
β-TCP and β-TCP/Al2O3 scaffolds were fabricated by 
using the gel-casting method. Ceramic slurries with solid 
content of 35 vol.-% were prepared by dispersing β-TCP 
powder in an aqueous solution containing 15 vol.-% of 
organic monomers (methacrylamide - MAM, Sigma-Aldrich, 
N,N,N’,N’-hydroxymethyl acrylamide - HMAM, Sigma-
Aldrich and methylenebisacrylamide - MBAM, Sigma-
Aldrich) at a molar ratio of 3:3:1 (MAM:HAMAM:MBAM). 
Ammonium polymethacrylate (Darvan® C-N, R.T. Vanderbilt 
Company, Inc.) was used as dispersant agent. Different 
amounts of alumina (5, 10 and 15 wt.-%) (Al2O3 – Alcoa, A 
1000-SG, Alcoa, d50 = 0.5 μm, ρ = 2.98 g.cm
-3) were added to 
produce the β-TCP/Al2O3 scaffolds. The slurries were finally 
homogenized with ball mills for 15 minutes. 
To produce the foam, non-ionic surfactant (Lutensol 
ON-110, BASF) was added to the slurry before being stirred 
for 2 minutes with a mixer. Ammonium persulfate (APS, 
Vetec) and N,N,N,N´-tetramethylethylenediamine (TEMED, 
Sigma-Aldrich) were used as initiator and catalyst for gelation 
reaction, respectively. The foams were dried at 50 ºC for 
24 hours and then the samples were core-drilled (cylinders, 
d = 7 mm and h = 14 mm). Heat treatment was performed 
as follows: samples were fired at 500 ºC (heating rate of 1 
ºC/min and dwell time of 1 hour) to eliminate all organic 
components; next, sintering was made at temperature of 
1200 ºC (heating rate of 5 ºC/min and dwell time of 2 hours).
2.2. Characterization
β-TCP and β-TCP/Al2O3 scaffolds were analyzed by X-ray 
diffraction (Shimadzu XRD7000, CuKα radiation, 2θ = 20-40º, 
30 mA, 40 k). The JCPDS database files used to identify the 
crystalline phases formed were 09-0169 for β-TCP, 09-0348 
for α-TCP and 10-0173 for Al2O3. The fracture surface of the 
sintered scaffolds was observed by using a scanning electron 
microscope (JEOL JSM6360-LV). The total porosity of the 
scaffolds was determined according to Equation (1)41. The 
geometric density (ρscaffold) of the cylindrical samples was 
calculated by using their dimensions (height and diameter) 
and weight. The theoretical density (ρHe) was calculated for 
each formulation according to Equation (2), where ρß-TCP and 
ρAl2O3 are the theoretical densities of β-TCP (3.07 g/cm
3) and 
Al2O3 (3.98 g/cm
3), respectively. X β-TCP and X Al2O3 are 
the mass fractions of each phase added.
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X-ray microtomographic images of β-TCP and β-TCP/
Al2O3 scaffolds were obtained by using a high resolution 
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X-ray microtomograph (SkyScan 1272 Bruker microCT, 
Kontich, Belgium) operating at 30 kV and 160 µA. The 
nominal resolution of 6.5 µm was obtained by using X-ray 
detector of 1224 x 820 pixels. NRecon software (Software 
Version 1.6.9.8, Bruker MicroCT®) was used to reconstruct 
cross-section images from microtomographic projections 
into 3D images based on the Feldkamp algorithm. The same 
electronic density contrast was selected for all samples in 
order to allow comparisons. The 3D images were viewed 
with CTVOX software (Version 2.7.0, Bruker MicroCT®), 
whereas 2D images per slices were obtained with Dataviewer 
software (Version 1.5.1.2, Bruker MicroCT®). Total porosity 
and pore size distribution were quantified by using the CT 
analyzer software (Version 1.14.4.1, Bruker MicroCT®). 
For acquisition of porosity parameters, the volume object 
of interest (VOI) was previously set to 4 mm3. 
The compressive strength of at least ten cylindrical 
samples (h/d = 2) was determined by using a universal 
testing machine (EMIC DL2000) at cross-head speed of 
0.5 mm.min-1.
2.3. Biological tests
In this study, osteoblast-like cells (MG 63) were obtained 
from the Rio de Janeiro Cell Bank (Rio de Janeiro, RJ, 
Brazil). The cells were cultured in DMEM (Cultilab Curitiba, 
Brazil), supplemented with 10% fetal bovine serum (FBS), 
penicillin (100 UI/mL), streptomycin (100 μg/mL) and then 
maintained at 37 °C and 5% of CO2. Cell culture flasks of 
75 mL and 250 cm2 were used. The culture medium was 
changed every two days and the cell growth was assessed 
by using a reverse phase microscope (Microlimaging GmbH 
- Axiovert 40C, Carl Zeiss Microscope, Jena, Germany).
2.3.1 Cell attachment 
For assessment of cell attachment and morphology of the 
cells in contact with the scaffolds, these were placed in 24-well 
plates and the cells plated on them before being maintained 
at 37 °C and 5% CO2. After 3-day growth of MG63 on the 
scaffolds, the cells were investigated by using SEM (Inspect 
S50, FEI Company, Brno, Czech Republic). For this, the 
culture medium was removed and the scaffolds were twice 
rinsed with PBS. The cells adhered in the scaffolds were fixed 
with 0.25% glutaraldehyde and 4% paraformaldehyde diluted 
in PBS before being dehydrated by a series of ascending 
ethanol concentrations (70%, 80%, 90% and 100% for 10 
minutes each). Next, the scaffolds were air-dried at room 
temperature for 24 hours. For SEM examination, the scaffolds 
were sputter-coated with palladium-gold alloy (Polaron SC 
7620 Sputter Coater, Quorum Technologies, Newhaven, UK) 
at a thickness of 7-10 nm (10-15 mA, under a vacuum of 
130 mTorr), with scanning electron microscope operating 
between 15-30 kV and spot 7.
2.3.2 Cytotoxicity
For the cytotoxicity test, 2x104 cells were plated in 24-
well plates and maintained at 37 °C and 5% CO2. After 24 
hours, the scaffolds were placed on the cells and the plates 
maintained at 37 °C and 5% CO2 for further 24 hours. Next, 
the viability of the cells put in contact with the scaffolds 
was determined by MTT assay (3-(4,5 dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide, Sigma, St Louis, MO, 
USA), which is a test that evaluates not only the number 
of cells, but also the level of their metabolic activity as 
it is based on the activity of enzymes, such as succicil 
dehydrogenase, present in viable cells42. MTT solution 
was added to each well and the cells were incubated for 
1 hour. Next, DMSO (dimethyl sulfoxide solvent, Sigma-
Aldrich, St Louis, MO, USA) was also added to each well 
and the plates were shaken at room temperature for 10 
minutes. The resulting optical density was measured in a 
spectrophotometer (Biotek-EL808IU, BioTek Instruments, 
Inc., Winooski, VT, USA) at 570 nm. The cytotoxicity was 
expressed as a percentage of the control group (100%) and 
the differences between values were statistically analyzed 
by ANOVA (P ≤ 0.05).
2.3.3 Genotoxicity
For assessment of the genotoxicity, 2x104 cells were 
plated in 24-well plates and maintained at 37 °C and 5% 
CO2 for 24 hours. After this period, the scaffolds were 
placed on the cells and the plates were maintained at 37 °C 
and 5% CO2 for further 24 hours. Next, the scaffolds were 
removed from the plates and the cells were rinsed with PBS 
and fixed with 4% paraformaldehyde diluted in PBS for 10 
minutes. PBS and Fluroshield with DAPI solution (Sigma, 
St Louis, MO, USA) were added to each well and the nuclei 
of the cells were observed by means of immunofluorescence 
and then photographed with a digital camera (Sony F828 
Digital, CyberShot, 8.0 megapixels) coupled to an inverted 
light microscope (Carl Zeiss Microscope Micro lmaging 
GmbH - Axiovert 40C, Germany). The micronucleus test 
is based on the loss of chromosomes or their fragments 
during cell mitosis. Entire chromosomes or their fragments 
not reincorporated by the nucleus after cell division lead to 
micronuclei formation43. A cell counter (Image J software) was 
used to assist in the counting of micronuclei. The micronuclei 
were determined microscopically at 1,000 cells/well and the 
differences between the values were statistically analyzed 
by using Mann-Whitney U test (P ≤ 0.05).
3. Results and Discussion
Figure 1 shows XRD patterns of the β-TCP and β-TCP/
Al2O3 scaffolds. Only β-TCP crystalline phase (JCPDS 09-
0169) was observed for β-TCP scaffold, whereas alumina 
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Figure 1. XDR patterns of the β-TCP and β-TCP/Al2O3 scaffolds. β=β-TCP; A=Al2O3.
(JCPDS 10-0173) was identified in all β-TCP/Al2O3 scaffolds 
(2θ = 35.13º, 43.36º and 57.51º). 
Figure 2 presents SEM micrographs of the fracture 
surface of the β-TCP and β-TCP/Al2O3 scaffolds. All 
scaffolds (Figure 2-B1, C1 and D1) presented homogeneous 
macro-structure with spherical and interconnected pores. 
The mean pore size varied from 200 to 500 μm, which is 
considered adequate for bone tissue growth11,27. For β-TCP 
scaffolds, it is possible to observe an inter-granular porosity. 
With regard to β-TCP/Al2O3 scaffolds, alumina particles 
filled the micro-porosity of the scaffolds, as can be seen 
in Figure 2 (B2-B3, C2-C3 and D2-D3). It can also be 
observed that the micro-structure of the scaffolds consists of 
two phases: calcium phosphate and small grains related to 
alumina. These results are in agreement with those reported 
by Ayed and Bouaziz35, who studied the effect of alumina 
addition on densification of tricalcium phosphate-26.52 
wt.-% fluorapatite composites.
Furthermore, in another study, high-density tricalcium 
phosphate-26.52 wt.-% fluorapatite-20 wt.-% zirconia composites 
were produced after sintering at various temperatures44. The 
authors observed that high temperatures (above 1300 ºC) 
or mass percentages of zirconia (near 20 wt.-%) are not the 
best conditions for composite densification. This is probably 
due to the new compound formation (CZ and TTCP). Also, 
it was observed that partial decomposition of TCP increases 
during the sintering process by the addition of zirconia (near 
20 wt.-%) at 1400 °C.
Table 1 shows the porosity values for β-TCP and β-TCP/
Al2O3 scaffolds, whose geometric porosities varied from 86 
to 88%, values higher than those reported in the literature. 
Therefore, the processing route influences the properties of 
the scaffolds. The comparison carried out here is between 
scaffolds made of other bioactive ceramic and high-porosity 
glass materials (~70%) and prepared by gel-casting method. 
Therefore, few reports were found. For example, Rehman 
and Zhang prepared hydroxyapatite scaffolds with porosities 
ranging from 70 to 77% by combining gel-casting and 
replica methods 45. Wu and collaborators produced bio-
glass scaffolds with 74-84% porosity by using a modified 
gel-casting of foams46. 
The porosity of β-TCP and β-TCP/Al2O3 scaffolds 
determined by microtomography varied from 70 to 77%, 
values lower than those obtained by geometric porosity for 
977Preparation, Characterization and Biological Studies of Β-TCP and Β-TCP/Al2O3 Scaffolds Obtained by 
Gel-Casting of Foams
Figure 2. SEM micrographs of β-TCP and β-TCP/Al2O3 scaffolds. (A1, A2, A3) β-TCP, (B1, B2, B3) β-TCP/Al2O3 – 95/5, (C1, C2, 
C3) β-TCP/Al2O3 – 90/10 and (D1, D2, D3) β-TCP/Al2O3 – 85/15.
all scaffolds. This result was already expected as meso- and 
nano-pores can be calculated by this method.
Moreover, it is necessary to point out that the presence 
of alumina does not influence the scaffold porosity.
X-ray microtomographic images were also used to 
obtain 3D images of the scaffolds, as shown in Figure 3. 
The color bar is proportional to the attenuation of X-rays 
passing through the scaffolds: colors on the left side show 
lower attenuation than those on the right side. The attenuation 
is influenced by changes in the sample, such as thickness, 
density and electronic density (basically, the atomic number 
of the involved samples). No significant changes in the 
micro-structures were observed in the scaffolds.
Different cross-sections of these images (Figure 4) 
provide a two-dimensional visualization of the interior of 
the scaffolds, showing a highly porous material. 
Figure 5 presents the 3D model obtained (Figure 3) 
and its pore size distribution. All samples show a wide pore 
size distribution, as observed in the SEM images, as well 
as similar porosity, confirming that alumina acts mainly as 
a filler for β-TCP grains.
Table 2 shows the compressive strength of β-TCP and 
β-TCP/Al2O3 scaffolds. By comparing between β-TCP and 
β-TCP/Al2O3 scaffolds, alumina did not improve the mechanical 
resistance of the former. This fact can be associated to the great 
difference in the sintering temperature of both powders. Another 
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Table 1. Porosity of β-TCP and β-TCP/Al2O3 scaffolds.
Methods
Porosity (%)
Concentration of alumina (%)
0 5 10 15
Geometrical 86.4 ± 1.0 87.1 ± 0.7 87.6 ± 0.7 87.5 ± 0.9
Microtomography 70.8 ± 0.3 73 ± 1.0 77 ± 1.0 75 ± 1.0
Figure 3. 3D images of the scaffolds obtained by X-ray microtomography: (a) β-TCP; (b) β-TCP/Al2O3 – 95/5; (c) β-TCP/Al2O3– 90/10 
and (d) β-TCP/Al2O3 – 85/15.
possibility could be the size of alumina particles, which are still 
in micrometer scale. In the literature, it is known that alumina 
particles are commonly used in micro-nanometric scale to 
improve the β-TCP densification during the sintering step. In 
the case of micrometric particles, these should be used in small 
amounts (≤ 2.5 wt.-%). This was confirmed by Bouslama et al., 
who used alumina as a promising material for reinforcement of 
calcium phosphate47.In their study, the mechanical properties 
of the β-TCP-fluorapatite composite was improved by adding 
2.5 wt.-% micro-sized alumina powder as additive.
In recent years, the use of nano-sized ceramic additives 
for strengthening bone substitutes has been studied. In 
the study by Ghzanfari et al.48, the effect of nano-alumina 
content on phase transformation and micro-structural and 
mechanical properties of HA/nAl2O3 scaffolds, fabricated 
by the freeze-casting method, was evaluated. Their results 
showed that the decomposition of HA to TCP was accelerated 
by increasing the nAl2O3 content at sintering temperature. 
In addition, the increase in the nAl2O3 content increased 
the pore size and the compressive strength of the scaffolds. 
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Figure 4. 2D slices of the 3D images obtained by X-ray microtomography: (a) β-TCP; (b) β-TCP/Al2O3 – 95/5; (c) β-TCP/Al2O3 – 90/10 
and (d) β-TCP/Al2O3 – 85/15.
Figure 5. 3D model re-constructed and mean pore size distribution for the scaffolds presented in Figure 3: (a) β-TCP; (b) β-TCP/Al2O3– 
95/5; (c) β-TCP/Al2O3 – 90/10 and (d) β-TCP/Al2O3 – 85/15.
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Table 2. Compressive strength of β-TCP and β-TCP/Al2O3 scaffolds.
Concentration of alumina (%)
0 5 10 15
Compressive strength (MPa) 0.37 ±0.05 0.21 ± 0.05 0.23 ±0.08 0.17 ±0.03
In another study, Hesaraki et al.49 studied the addition of 
alumina and silica nano-particles to produce beta-tricalcium 
phosphate scaffolds, resulting in improved mechanical and 
biological properties.
Therefore, we intend to use nano-sized particles in further 
works to obtain bio-ceramic scaffolds by gel-casting method, 
since this method is still little explored in the literature and 
allows the production of highly porous scaffolds with highly 
interconnected spherical pores, which would promote cell 
growth within the structure.
As it is known, porosity and mechanical strength are 
inversely proportional properties. Therefore, the low values 
found for the mechanical strength of β-TCP and β-TCP/
Al2O3 scaffolds were already expected. However, our results 
indicated that the compressive strength of ~0.2–0.4 MPa is 
sufficient for the scaffolds to be handled and manipulated 
during all tests. The compressive strength of spongy bone is 
in the range of 0.2–4.0 MPa when the relative density is 0.150. 
Figure 6. Cell spreading on the samples after 3 days, as observed by SEM: (A) β-TCP; (B) β-TCP/Al2O3 – 95/5; 
(C) β-TCP/Al2O3 – 90/10 and (D) β-TCP/Al2O3 – 85/15.
Hence, the compressive strength of the present scaffolds falls 
in this range, but lies closer to the lower bound. It has also 
been speculated that it might not be necessary to fabricate 
a scaffold with mechanical strength equal to that of bone 
because cells cultured on scaffolds and in vitro formation 
of new tissues will create a bio-composite and will increase 
the time-dependent strength of the scaffold significantly25.
Cell attachment was observed in all scaffolds. There was 
an intimate contact between the cells as they were scattered 
all over the surface (Figure 6).
Cell viability was analyzed by MTT assay and the 
average percentages of absorbance values measured for each 
concentration are shown in Figure 7. The data obtained in 
this test were statistically analyzed by using ANOVA, which 
showed that there was no statistical difference between 
control (100%) and experimental groups (P > 0.05). Thus, 
none of the concentrations tested was found to be cytotoxic 
to the cells. Moreover, there was no statistical difference 
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Figure 7. Graph showing mean percentage of absorbance, obtained 
with MTT assay, after contact of the cells with β-TCP/Al2O3 
scaffolds for 24 hours.
between the groups regarding the amount of alumina used 
(P > 0.05). These results indicate that different amounts 
of alumina within β-TCP did not affect the cell viability, 
which was already expected as β-TCP and Al2O3 have been 
investigated and exhibited high biocompatibility51-53.
Genotoxicity was evaluated in this study through 
the micronucleus test. The DNA structures contained 
in the cytoplasm are clearly separated from the main 
nuclei as their area is 1/3 smaller, thus being considered 
as micro-nuclei (Figure 8). Only cells containing less 
than five micronuclei were counted, whereas mitotic 
and apoptotic cells were not.
The mean number of micronuclei observed in this study 
(1,000 cells/well) can be observed in Figure 9. There was 
no statistical difference between control and experimental 
groups regarding the number of micronuclei (P > 0.05), 
although β-TCP scaffolds have presented the highest number 
of micronuclei. Furthermore, the groups were not statistically 
different from each other (P > 0.05). These results were 
Figure 8. Photomicrography of MG-63 nuclei after contact of the 
cells with β-TCP/Al2O3– 85/15 for 24 hours. Note the presence 
of a micronucleus (arrow) in this site (Fluroshield with DAPI 
Immunofluorescence staining; original magnification x20).
Figure 9. Graph showing number of micronuclei in 1,000 cells/well 
after contact of the cells with β-TCP/Al2O3 scaffolds for 24 hours.
already expected as no degree of cytotoxicity had been 
previously observed in this study and β-TCP scaffold is 
known to be biocompatible47. According to Tsaousi et al.54, 
alumina particles are weakly genotoxic only to human cells 
in vitro and the induction of micronuclei is not affected by 
the size or shape of the particles. However, in our study, 
different amounts of alumina added to β-TCP scaffold were 
not found to be genotoxic to the cells.
Based on the results above, β-TCP and β-TCP/Al2O3 
scaffolds produced by gel-casting method showed good 
characteristics, such as high porosity, interconnected 
pores with spherical geometry and pore size in the 
range of 200-500 µm, which make these scaffolds good 
candidates for use in tissue engineering.
4. Conclusions
It was possible to obtain β-TCP and β-TCP/Al2O3 
scaffolds with high porosity (> 86%) and spherical and 
interconnected pores by using the gel-casting method. 
All scaffolds showed cytocompatibility with no cytotoxic 
and genotoxic effects. These findings indicate a possible 
application of this β-TCP/Al2O3 scaffold for bone tissue 
engineering.
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